Sick sinus syndrome: decompensation prevention
In 83 patients with sick sinus syndrome and without severe impairment of central/systemic hemodynamics (compensated SSS), decompensation prevention by long-tem atenolol therapy was investigated. Follow-up lasted for 6-24 months, mean atenolol dose was 26,2+3,5 mg/d. In patients with initially decrea...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2004-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2330 |
_version_ | 1797857297754488832 |
---|---|
author | V. M. Provotorov Z. S. Shatilova M. L. Glukhovsky |
author_facet | V. M. Provotorov Z. S. Shatilova M. L. Glukhovsky |
author_sort | V. M. Provotorov |
collection | DOAJ |
description | In 83 patients with sick sinus syndrome and without severe impairment of central/systemic hemodynamics (compensated SSS), decompensation prevention by long-tem atenolol therapy was investigated. Follow-up lasted for 6-24 months, mean atenolol dose was 26,2+3,5 mg/d. In patients with initially decreased heart rate (HR) during pharmaceutical autonomous blockade (PAB) test, treatment was associated with substantial decline in congestive heart failure and chronic atrial fibrillation incidence. Atenolol intolerance was predicted by prolonged sinus node recovery time in baseline PAB test (by 280 sec or more). No significant influence on syncope or pacemaker implantation incidence was observed. |
first_indexed | 2024-04-09T20:54:23Z |
format | Article |
id | doaj.art-8765634613b74aa68601c2cc943eb717 |
institution | Directory Open Access Journal |
issn | 1560-4071 2618-7620 |
language | Russian |
last_indexed | 2024-04-09T20:54:23Z |
publishDate | 2004-12-01 |
publisher | «FIRMA «SILICEA» LLC |
record_format | Article |
series | Российский кардиологический журнал |
spelling | doaj.art-8765634613b74aa68601c2cc943eb7172023-03-29T21:23:11Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202004-12-010674772076Sick sinus syndrome: decompensation preventionV. M. Provotorov0Z. S. Shatilova1M. L. Glukhovsky2Воронежская государственная медицинская академия имени Н.Н.БурденкоВоронежская государственная медицинская академия имени Н.Н.БурденкоВоронежская государственная медицинская академия имени Н.Н.БурденкоIn 83 patients with sick sinus syndrome and without severe impairment of central/systemic hemodynamics (compensated SSS), decompensation prevention by long-tem atenolol therapy was investigated. Follow-up lasted for 6-24 months, mean atenolol dose was 26,2+3,5 mg/d. In patients with initially decreased heart rate (HR) during pharmaceutical autonomous blockade (PAB) test, treatment was associated with substantial decline in congestive heart failure and chronic atrial fibrillation incidence. Atenolol intolerance was predicted by prolonged sinus node recovery time in baseline PAB test (by 280 sec or more). No significant influence on syncope or pacemaker implantation incidence was observed.https://russjcardiol.elpub.ru/jour/article/view/2330sick sinus syndromecompensationatenololheart failure |
spellingShingle | V. M. Provotorov Z. S. Shatilova M. L. Glukhovsky Sick sinus syndrome: decompensation prevention Российский кардиологический журнал sick sinus syndrome compensation atenolol heart failure |
title | Sick sinus syndrome: decompensation prevention |
title_full | Sick sinus syndrome: decompensation prevention |
title_fullStr | Sick sinus syndrome: decompensation prevention |
title_full_unstemmed | Sick sinus syndrome: decompensation prevention |
title_short | Sick sinus syndrome: decompensation prevention |
title_sort | sick sinus syndrome decompensation prevention |
topic | sick sinus syndrome compensation atenolol heart failure |
url | https://russjcardiol.elpub.ru/jour/article/view/2330 |
work_keys_str_mv | AT vmprovotorov sicksinussyndromedecompensationprevention AT zsshatilova sicksinussyndromedecompensationprevention AT mlglukhovsky sicksinussyndromedecompensationprevention |